| | | | | | What you need to know about the coronavirus today | | | Seoul orders masks on, indoors and out South Korea’s capital on Monday ordered people to wear masks in indoor and outdoor public places for the first time, as it battles a surge in coronavirus cases. South Korea’s coronavirus battle has been complicated by a fight between President Moon Jae-in’s administration and the Sarang Jeil Church, the second religious group at the center of a major cluster of cases.
Get children back to school, says British prime minister British Prime Minister Boris Johnson called on parents to send their children back to school next month after the summer holidays. “The risk of contracting COVID-19 in school is very small and it is far more damaging for a child’s development and their health and well-being to be away from school any longer,” Johnson said.
Auckland lockdown extended New Zealand Prime Minister Jacinda Ardern extended a coronavirus lockdown in the country’s largest city, Auckland, until the end of the week and introduced mandatory mask wearing on public transport across the nation. Neighboring Australia reported its lowest one-day rise in new coronavirus infections in almost two months on Monday, raising hopes that a deadly second wave is subsiding.
Bali tourism plan on hold The Indonesian island of Bali has postponed a plan to reopen its biggest tourism hub to international visitors on Sept. 11, due to the rising level of coronavirus cases, its governor said. Tourism is Bali’s main source of income and travel restrictions have hammered the economy. | | | | From Breakingviews - Corona Capital: Pearson’s CEO, Afterpay, Tourism Pearson’s new boss is expected to work some Disney magic as the virus hastens the shift to online textbooks, and Australia’s Afterpay buys now in Europe – and may pay later. Catch up with the latest financial insights. | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Here’s a look at our coverage.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | Politics | | | White House adviser Kellyanne Conway said she will be leaving the administration of U.S. President Donald Trump at the end of August, citing the need to focus on her family. “I will be transitioning from the White House at the end of this month,” she said in a statement. Her departure, about two months before Trump seeks re-election, comes at a crucial time for the president. It leaves him without one of his more passionate spokespersons about his political and policy choices. | | When Donald Trump was elected president in 2016, almost immediately, and with evident relish, he set about trying to demolish Barack Obama’s carefully crafted foreign policy legacy. But despite the widespread ill-feeling Trump has provoked, not all his policy legacy will be hurled out of the window, and neither long-term allies nor strategic rivals expect a soft touch from Biden, vice president under Obama and a former senator with decades of foreign policy experience. | | | COVID Science | Italy kicked off human trials of a potential COVID-19 vaccine, joining a global effort to develop a response to the virus which has shown signs of resurging in Europe.
Rome’s Lazzaro Spallanzani institute, a hospital specializing in infectious diseases will conduct trials on 90 volunteers over the coming weeks, with the hope a vaccine may be available by spring of next year. | | | | | | | | | Top Stories on Reuters TV | | | | | | | |